C
Christian M. Zechmann
Researcher at Heidelberg University
Publications - 68
Citations - 5167
Christian M. Zechmann is an academic researcher from Heidelberg University. The author has contributed to research in topics: Magnetic resonance imaging & Monoclonal gammopathy of undetermined significance. The author has an hindex of 26, co-authored 68 publications receiving 4632 citations. Previous affiliations of Christian M. Zechmann include German Cancer Research Center & University Hospital Heidelberg.
Papers
More filters
Journal ArticleDOI
3D printing based on imaging data: review of medical applications
Fabian Rengier,Fabian Rengier,Amit Mehndiratta,Amit Mehndiratta,H. von Tengg-Kobligk,H. von Tengg-Kobligk,Christian M. Zechmann,Christian M. Zechmann,Roland Unterhinninghofen,H. U. Kauczor,Frederik L. Giesel,Frederik L. Giesel +11 more
TL;DR: Medical application of rapid prototyping is feasible for specialized surgical planning and prosthetics applications and has significant potential for development of new medical applications.
Journal ArticleDOI
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh,Christian M. Zechmann,Anna Malcher,Matthias Eder,Michael Eisenhut,Heinz G. Linhart,Tim Holland-Letz,Boris Hadaschik,Frederik L. Giesel,Jürgen Debus,Uwe Haberkorn +10 more
TL;DR: 68Ga-PSMA PET/CT can detect lesions characteristic for PC with improved contrast when compared to standard 18F-fluoromethylcholine PET/ CT, especially at low PSA levels.
Journal ArticleDOI
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Ali Afshar-Oromieh,A. Malcher,Matthias Eder,Michael Eisenhut,Heinz G. Linhart,Boris Hadaschik,Tim Holland-Letz,F. L. Giesel,Clemens Kratochwil,Sabine Haufe,Uwe Haberkorn,Christian M. Zechmann +11 more
TL;DR: The biodistribution of the novel 68Ga-PSMA tracer and its ability to detect PC lesions was analysed in 37 patients to suggest that this novel tracer can detect PC relapses and metastases with high contrast.
Journal ArticleDOI
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann,Ali Afshar-Oromieh,Tom Armor,James B. Stubbs,Walter Mier,Boris Hadaschik,John Joyal,Klaus Kopka,Jürgen Debus,John W. Babich,Uwe Haberkorn +10 more
TL;DR: Tissue kinetics of a small molecule inhibitor of PSMA using PET/CT to estimate radiation dosimetry for the potential therapeutic use of 131I-MIP-1095 in men with mCRPC enables a targeted tumor therapy with unprecedented doses delivered to the tumor lesions.
Journal ArticleDOI
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
TL;DR: The initial experience with Ga-PSMA PET/CT strongly suggests that this novel method can detect prostate carcinoma relapses and metastases with significantly improved contrast compared to F-FECHPET/CT.